Imaging of dopamine D2/3 agonist binding in cocaine dependence: A [11C]NPA positron emission tomography study

Synapse

Volumn 65, Issue 12, 2011, Pages 1344-1349

  Narendran, Rajesh ^a   Martinez, Diana ^b   Mason, Neale Scott ^a   Lopresti, Brian J ^a   Himes, Michael L ^a   Chen, Chi Min ^a   May, Maureen A ^a   Price, Julie C ^a   Mathis, Chester A ^a   Frankle, W Gordon ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

11C N propyl norapomorphine (NPA); 11C raclopride; Cocaine dependence; Positron emission tomography (PET)

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; PROPYLNORAPOMORPHINE; PROPYLNORAPOMORPHINE C 11; RACLOPRIDE C 11; UNCLASSIFIED DRUG; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; N-N-PROPYLNORAPOMORPHINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR AFFINITY; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG POTENTIATION; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

ADOLESCENT; ADULT; APOMORPHINE; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; YOUNG ADULT;

EID: 80053909049     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20970     Document Type: Article

References (26)

1. Abi-Dargham A, Laruelle M, Seibyl J, Rattner Z, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Bremner JD, Hyde TM, Charney DS, Hoffer PB, Innis RB. 1994. SPECT measurement of benzodiazepine receptors in human brain with [123-I]iomazenil: Kinetic and equilibrium paradigms. J Nucl Med 35: 228-238.
2. Briand LA, Flagel SB, Seeman P, Robinson TE. 2008. Cocaine self-administration produces a persistent increase in dopamine D2(High) receptors. Eur Neuropsychopharmacol 18: 551-556.
3. Gandelman MS, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Innis RB. 1994. Evaluation of ultrafiltration for the free fraction determination of single photon emission computerized tomography (SPECT) radiotracers: β-CIT. IBF and iomazenil. J Pharmaceutical Sci 83: 1014-1019.
4. Halldin C, Farde L, Hogberg T, Hall H, Strom P, Ohlberger A, Solin O. 1991. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding. Int J Rad Appl Instrum B 18: 871-881.
5. Hwang D, Kegeles LS, Laruelle M. 2000. (-)-N-[(11)C]propyl-norapomorphine: A positron-labeled dopamine agonist for PET imaging of D(2) receptors. Nucl Med Biol 27: 533-539.
6. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533-1539.
7. 11C]raclopride studies. J Cereb Blood Flow Metab 16: 42-52.
8. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, Cooper T, Kegeles L, Zarahn E, Abi-Dargham A, Haber SN, Laruelle M. 2003. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285-300.
9. Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y, Perez A, Frankle WG, Cooper T, Kleber HD, Fischman MW, Laruelle M. 2004. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: Relationship with cocaine-seeking behavior. Neuropsychopharmacology 29: 1190-1202.
10. Martinez D, Narendran R, Foltin R, M S, Hwang D-R, Broft A, Huang Y, Cooper T, Fischman M, Kleber H, Laruelle M. 2007. Amphetamine-induced dopamine release is markedly blunted in cocaine dependent subjects and predictive of the choice to self administer cocaine. Am J Psychiatry 164: 622-629.
11. Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R, Slifstein M, Van Heertum R, Kleber HD. 2009. Lower level of endogenous dopamine in patients with cocaine dependence: Findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Am J Psychiatry 166: 1170-1177.
12. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M. 2001. Imaging human mesolimbic dopamine transmission with positron emission tomography. I. Accuracy and precision of D2 receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21: 1034-1057.
13. Narendran R, Martinez D. 2008. Cocaine abuse and sensitization of striatal dopamine transmission: A critical review of the preclinical and clinical imaging literature. Synapse 62: 851-869.
14. Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M. 2004. In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride. Synapse 52: 188-208.
15. Narendran R, Frankle WG, Mason NS, Laymon CM, Lopresti B, Price CJ, Kendro S, Vora S, Litschge M, Mountz JM, Mathis C. 2009. PET Imaging of D2/3 agonist binding in healthy human subjects with the radiotracer [11C]-N-propyl-nor-apomorphine (NPA): Preliminary evaluation and reproducibility studies. Synapse 63: 574-584.
16. Narendran R, Mason NS, Laymon C, Lopresti B, Velasquez N, May M, Kendro S, Martinez D, Mathis C, Frankle G. 2010. A comparative evaluation of the dopamine D2/3 agonist radiotracer [11C]NPA and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum. J Pharmacol Exp Therap 63: 574-584.
17. Narendran R, Mason NS, Chen CM, Himes M, Keating P, May MA, Rabiner EA, Laruelle M, Mathis CA, Frankle WG. 2011. Evaluation of dopamine D(2/3) specific binding in the cerebellum for the positron emission tomography radiotracer [(11) C]FLB 457: Implications for measuring cortical dopamine release. Synapse 65: 991-997.
18. Rabiner EA, Slifstein M, Nobrega J, Plisson C, Huiban M, Raymond R, Diwan M, Wilson AA, McCormick P, Gentile G, Gunn RN, Laruelle MA. 2009. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice. Synapse 63: 782-793.
19. Searle G, Beaver JD, Comley RA, Bani M, Tziortzi A, Slifstein M, Mugnaini M, Griffante C, Wilson AA, Merlo-Pich E, Houle S, Gunn R, Rabiner EA, Laruelle M. 2010. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist. Biol Psychiatry 68: 392-399.
20. Seeman P. 2009. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals. Synapse 63: 186-192.
21. Seeman P, Tallerico T, Ko F, Tenn C, Kapur S. 2002. Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges. Synapse 46: 235-239.
22. Seeman P, McCormick PN, Kapur S. 2007. Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO. Synapse 61: 263-267.
23. Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue CY, Alpert R, Dewey SL, Logan J, Bendriem B, Christman D, Hitzemann R, Henn F. 1990. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 147: 719-724.
24. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP. 1993. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14: 169-177.
25. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N. 1997. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830-833.
26. Wu JC, Bell K, Najafi A, Widmark C, Keator D, Tang C, Klein E, Bunney BG, Fallon J, Bunney WE. 1997. Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology 17: 402-409.